ANIK
Anika Therapeutics
$21.55
+$0.20 (+0.94%)Oct 28, 2026
Key metrics
The numbers that frame ANIK today
- Market cap
- $288.40M
- EV / FCF
- 486.3
- Gross margin
- 62.2%
- EV / Sales
- 2.3
- ROIC
- -2.8%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $9.01
- 52wk High
- $22.88
Growth
Revenue and earnings trend for ANIK
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ANIK
Is Anika Therapeutics a good buy?
Yes. Anika Therapeutics has excellent quality and excellent momentum. Both signals support the setup. Growth looks strong, which supports the long-term business case. We think Anika Therapeutics is selling at a high price, which cuts against the buy case.
What is the market capitalization of ANIK?
Anika Therapeutics's market capitalization is $288.40M.
What is the 52-week high for ANIK stock?
The 52-week high for Anika Therapeutics is $22.88. The current close of $21.55 is 5.8% below that high.
What is the 52-week low for ANIK stock?
The 52-week low for Anika Therapeutics is $9.01. The current close of $21.55 is 139.2% above that low.
Does ANIK stock pay dividends?
Anika Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ANIK?
Anika Therapeutics's Debt / Equity ratio is 0.17.